Douglas Pharmaceuticals Announces Formation of Clinical Advisory Board for Lead Program R-107
AUCKLAND, New Zealand, Jan. 26, 2023 /PRNewswire/ -- Douglas Pharmaceuticals, a New Zealand Pharmaceutical company focused on specialty generic and repurposed drug development, today announced